FOLH1 and neoplasm: Based on these strategies, to make NK cells more specifically recognize and kill PCa cells and to reduce the NK cell dosage, we successfully constructed CAR-NK cells targeting the prostate-specific membrane antigen (PSMA), and subsequently demonstrated their specific anti-tumor effects against PCa (13).